Quanta Lite Gpa (Gastric Parietal Cell Antibody) Elisa
FDA 510(k) K010558 · Inova Diagnostics, Inc.
510(k) numberK010558
Submission
- Device name
- Quanta Lite Gpa (Gastric Parietal Cell Antibody) Elisa
- Applicant
- Inova Diagnostics, Inc.
San Diego, CA, US - Received
- February 26, 2001
- Decision date
- April 3, 2001
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) statement available from FDA
Device classification
- Product code
- MLE – Enzyme Immunoassay, Antiparietal Cell Antibody, Antigen, Control
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.5110
- Specialty
- Immunology
Other 510(k)s with product code MLE
More from Elias U.S.A., Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K243979 | Aptiva APS IgA ReagentMSV · Traditional | 02/06/2026SE |
| K223093 | Aptiva APS IgG Reagent; Aptiva APS IgM ReagentMID · Traditional | 12/17/2024SE |
| K213403 | Aptiva CTD Essential ReagentLLL · Traditional | 09/29/2023SE |
| K200230 | Aptiva Celiac Disease IgG ReagentMVM · Traditional | 08/26/2021SE |
| K193604 | Aptiva Celiac Disease IgA ReagentMVM · Traditional | 06/16/2021SE |
| K192916 | NOVA Lite DAPI dsDNA Crithidia luciliae KitKTL · Traditional | 12/11/2020SE |
| K190088 | QUANTA Flash RF IgM Reagents, QUANTA Flash RF IgA ReagentsDHR · Traditional | 04/17/2019SE |
| K180971 | QUANTA Flash Calprotectin and Fecal Extraction DeviceNXO · Traditional | 10/16/2018SE |
| K180975 | QUANTA Flash HMGCR ReagentsLLL · Traditional | 06/25/2018SE |
| K170993 | QUANTA Flash Calprotectin Reagents, QUANTA Flash Calprotectin Calibrators, QUANTA Flash…NXO · Traditional | 12/22/2017SE |
Questions and answers
When was Quanta Lite Gpa (Gastric Parietal Cell Antibody) Elisa cleared by the FDA?
Quanta Lite Gpa (Gastric Parietal Cell Antibody) Elisa (K010558) received a 510(k) decision of Substantially Equivalent on April 3, 2001, 36 days after the submission was received.
What is the product code of K010558?
The FDA product code is MLE – Enzyme Immunoassay, Antiparietal Cell Antibody, Antigen, Control, a Class II (moderate risk) device regulated under 21 CFR 866.5110.